This document discusses the polymorphisms of the dopamine receptor D4 and their effect on dopamine regulation in attention deficit hyperactivity disorder (ADHD). It defines ADHD and its subtypes, explores its pathophysiology including the roles of neurotransmitters like dopamine and the dopamine transporter DAT1. Symptoms and diagnosis of ADHD are outlined, noting that diagnosis is based on a professional's opinion. The document also discusses various treatments for ADHD including medications, behavioral therapies, dietary modifications, and alternative therapies. It concludes by calling for more scientific data and research into ADHD to improve understanding of this common but misunderstood condition.
6. THE POLYMORPHISMS OF DOPAMINE RECEPTOR D4
AND THEIR EFFECT ON DOPAMINE REGULATION, IN
THE MANIFESTATION OF ATTENTION DEFICIT
HYPERACTIVITY DISORDER (ADHD)
By Tammy Alsop Sheffield Hallam University
7. BACKGROUND AND DEFINITION
• Aetiological factors include: Genetics/neurobiology, Environmental, Social and
Psychological.
• ADHD is defined by the American diagnostic and statistical manual of mental health
as a persistent pattern of inattention and/or hyperactivity – impulsivity that
interferes with functioning or development as characterised by the set
criteria.
• Subtypes
Inattentive
Hyperactive
Combined type
10. SYMPTOMS AND DIAGNOSIS
• Conditions with overlapping symptoms such as
Autism or learning difficulties
• ADHD presents with co-morbid conditions such as
sensory processing disorder (SPD)
• Ultimately the diagnosis is based on professional
opinion of the attending paediatrician/psychiatrist
• Symptomology is variable but must show at least 6 of
9 characteristics from either subtype.
11. TREATMENTS
Medication
• Medication in the UK is only
given to severe ADHD cases.
• There are 2 types of
stimulants
• There are also non stimulants
such as Atomoxetine
Behavioural and
parental therapy
• CBT
• Parent coping courses
• Occupational therapy
• Education and learning
programmes
Alternative and Diet
• Dietary modifications such
as avoidance of sugar,
caffeine and artificial
additives
• Dietary supplements to
combat deficiencies such
as zinc, magnesium and
omega-3 commonly
found in ADHD patients.
• Meditation and
mindfulness
• Exercise
12. CONCLUSION
• Scientific data and further research are a necessity.
• Raising awareness of such a common but misunderstood unseen condition will be
highly beneficial.
Isn’t that the goal of Healthcare as a whole ?
Editor's Notes
Im gna start with a question
WHAT IS YOUR FIRST THOUGHT UPON SEEING THIS WORD ?
Many of you will have misconceptions about the origins and treatments of ADHD without actually knowing any real scientific information.
While the actual cause has not been pinpointed there is evidence to suggest a neurobiological/genetic basis.
I started a poll over social media to engage those who live with ADHD daily, to find out what misconceptions exist.
I got 3094 Replies with the main misconception being poor parenting.
I got 3094 Replies with the main misconception being that ADHD is an excuse for poor parenting!
The results are presented here in a graph.
33% of 3094 people were faced with the bad parenting misconception.
I think more scientific research is necessary to alleviate the stereotypical view of ADHD and provide scientific evidence to support a neurobiological approach.
So my literature review is focused on the polymorphisms of the dopamine receptor D4 and how this translates into the development of ADHD. I also chose this because my son has recently been diagnosed with a severe form of ADHD and I’m passionate about the role of genetics in the development of heterologous conditions as it influences individual treatment options which impact on quality of life. This is where my career focus is based and I would like to go on to sequence and identify genetic variants indicative of disease which ties into my project with Lucy crooks on bioinformatic sequencing.
Adhd is a heterologous neurological condition with many causative factors to consider.
Research has suggested that Genetics – neurobiology, Environmental, Social and Psychological Factors are all associated.
Deficiencies such as zinc and magnesium have also been linked to ADHD.
But This presentation will focus on the neurobiological/genetic aspect of the aetiology.
In America the diagnostic and statistical manual of mental health defines ADHD as a persistent pattern of inattention and/or hyperactivity – impulsivity that interferes with functioning or development as characterised by the set criteria.
In Britain however the WHO uses the ICD10, which stands for International Classification of Disease, to define and diagnose ADHD with slight differences to the diagnostic criteria.
There are 3 main subtypes of ADHD
Inattentive - predominantly diagnosed in females
Hyperactive- impulsive
Combined type
The pathophysiology of ADHD is complex and involves specific neurotransmitters and Brain regions.
Dopamine and Noradrenaline are the most common recognised deficits, causative of the symptomology seen in those with ADHD.
Norepinephrine is associated with concentration and impulse control
Dopamine is responsible for the pleasure and reward system and our motivational drive, So a dysregulation in the brain would result in issues with understanding consequence and motivation, poor impulse control and inattention.
Typical features of those with ADHD.
These neurotransmitters (or lack their of) directly correlate to the 3 main areas of difficulty identified in ADHD.
*Inattention *Hyperactivity and *Impulsivity.
Brain studies suggest that dysregulation occurs due to mutations in the dopamine receptor DRD4 and the overexpression of the dopamine transporter DAT1.
This image highlights what is going on at the synaptic clefts between axon terminals in the brain. If DRD4 receptors (shown in pink) are mutated, this would lower the binding affinity of dopamine and result in ineffective dopaminergic neurotransmission. Furthermore overexpression of DAT1 transporters (shown in red) would reabsorb the dopamine (shown in blue) in the synaptic cleft, effectively limiting the interaction time between dopamine and the DRD4 receptors.
MRI brain scanning has shown that people with ADHD have marked differences and structural abnormalities in specific brain regions.
These include the cortical an subcortical regions in particular the prefrontal cortex ( controls self regulation, memory, planning and attention) and the basal ganglia (controls cognitive learning, habit formation, emotional control and coordination) respectively.
The prefrontal cortex has been found to be smaller in adhd patients.
The cerebellum is also affected ( controls coordination of movement and timing)
The neuroactivity is disrupted, with underactivity being observed in the prefrontal region of those with ADHD as opposed to a control subject of the same age shown in this image on the left.
Overall the total brain volume is alot less.
Diagnosis is complex due to the amount of conditions with overlapping symptoms
and also because often ADHD presents with co-morbid conditions such as sensory processing disorder (SPD)
Diagnosis must follow specific criteria (DSM-V) but ultimately the diagnosis is based on professional opinion of the attending paediatrician/psychiatrist which leaves room for error and can often lead to misdiagnosis.
Symptomology is variable as shown in the image there and not all those with ADHD will present with every symptom.
However they must meet at least 6 of 9 characteristics in the diagnostic criteria, from either category of inattention or hyperactivity- impulsivity.
If 6 characteristics are met from both categories then the person will be diagnosed with the 3rd subset ; combined type.
2 types of stimulants
Equasym with the active ingredient being methylphenidate and (work by
Adderall which is an amphetamine (work by
There are also non stimulant medications such as atomoxetine (work by
For mild to moderate cases therapies are tried first which address a variety of different issues such as movement, academia, parenting, understanding emotions and self esteem. If therapy is ineffective medication is used (last resort)
Diet and lifestyle are often used to lessen ADHD symptoms in children whose parents do not want to medicate.
Dietary modifications (caffeine, sugar) and supplementations such as omega-3, zinc and magnesium have no scientific evidence of benefit or risk however it has been shown that there is a higher prevalence of specific deficiencies seen in these patients.
Ive illustrated the neurobiological basis of ADHD and I hope I have cleared up some of the misconceptions that people have.
Scientific data and further research will help to improve our knowledge and understanding of this complex condition to aid the discovery of potential novel treatment paths.
It will also raise awareness so people will seek out the necessary diagnosis and treatment without fear of the stigma attached, which may have a beneficial impact on the quality of the people who suffer at the hands of a debilitating unseen condition.
Isnt that the aim of Healthcare research???